News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market



8/18/2009 7:31:09 AM

ABBOTT PARK, Ill., Aug. 18 /PRNewswire/ -- Abbott announced today they have partnered with Velcera, Inc., a specialty pharmaceutical company focused on pet health, to market the first canine pain management product delivered in a transmucosal mist form. Currently in clinical trials, the product combines the proven pain medication meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) with Velcera's patented Promist(TM) technology, and has been globally licensed for pain management in dogs.

Read at PR Newswire


comments powered by Disqus
Velcera
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES